CA2673193C - Preparations homogenes de pate et de gel - Google Patents
Preparations homogenes de pate et de gel Download PDFInfo
- Publication number
- CA2673193C CA2673193C CA2673193A CA2673193A CA2673193C CA 2673193 C CA2673193 C CA 2673193C CA 2673193 A CA2673193 A CA 2673193A CA 2673193 A CA2673193 A CA 2673193A CA 2673193 C CA2673193 C CA 2673193C
- Authority
- CA
- Canada
- Prior art keywords
- veterinary
- pharmaceutical
- paste
- paragraph
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Cette invention concerne une préparation de pâte ou de gel pharmaceutique ou vétérinaire, qui peut comprendre: une quantité efficace d'un agent thérapeutique; éventuellement un absorbant ou un modificateur de viscosité; éventuellement un excipient hydrophile, un colorant, un stabilisant, un surfactif, ou un agent de préservation et éventuellement un antioxydant, un solvant, un aromatisant, un système tampon ou un épaississant; et des méthodes de fabrication de ces préparations. L'invention concerne également, entre autres, des pâtes ou des gels homogènes vétérinaires administrables par voie orale, destinés au traitement, à l'éradication et à la prévention d'infections par les endoparasites et les ectoparasites chez les animaux à sang chaud, tels que les oiseaux, les chevaux et les animaux de compagnie.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
USPCT/US2006/048672 | 2006-12-19 | ||
PCT/US2006/048672 WO2007075827A2 (fr) | 2005-12-20 | 2006-12-19 | Formulations de pates homogenes |
US11/713,881 | 2007-03-05 | ||
US11/713,881 US20080027011A1 (en) | 2005-12-20 | 2007-03-05 | Homogeneous paste and gel formulations |
PCT/US2007/088225 WO2008077130A2 (fr) | 2006-12-19 | 2007-12-19 | Préparations homogènes de pâte et de gel |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2673193A1 CA2673193A1 (fr) | 2008-06-26 |
CA2673193C true CA2673193C (fr) | 2014-08-05 |
Family
ID=40984939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2673193A Active CA2673193C (fr) | 2006-12-19 | 2007-12-19 | Preparations homogenes de pate et de gel |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2101736A4 (fr) |
CA (1) | CA2673193C (fr) |
MX (1) | MX2009006656A (fr) |
WO (1) | WO2008077130A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10137111B2 (en) | 2016-08-11 | 2018-11-27 | Adamis Pharmaceuticals Corporation | Drug compositions comprising an anti-parasitic and proton pump inhibitor |
WO2019113493A1 (fr) | 2017-12-08 | 2019-06-13 | Adamis Pharmaceuticals Corporation | Compositions de médicaments |
CN111801068A (zh) * | 2018-01-18 | 2020-10-20 | 硕腾布鲁姆希尔Ip有限公司 | 内部乳头密封剂及其在预防干奶牛的牛乳腺炎中的应用 |
US10857151B1 (en) * | 2020-02-21 | 2020-12-08 | Villya LLC | Treatment of female genital schistosomiasis |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6787342B2 (en) * | 2000-02-16 | 2004-09-07 | Merial Limited | Paste formulations |
US20040151759A1 (en) * | 2002-08-16 | 2004-08-05 | Douglas Cleverly | Non-animal product containing veterinary formulations |
WO2005063184A1 (fr) * | 2003-12-22 | 2005-07-14 | Imrex, Inc. | Methodes et compositions d'hygiene buccale |
JP5577021B2 (ja) * | 2005-02-17 | 2014-08-20 | アボット・ラボラトリーズ | 動物における障害を治療および予防するための薬剤組成物の経粘膜投与 |
-
2007
- 2007-12-19 MX MX2009006656A patent/MX2009006656A/es not_active Application Discontinuation
- 2007-12-19 CA CA2673193A patent/CA2673193C/fr active Active
- 2007-12-19 EP EP07869573A patent/EP2101736A4/fr not_active Withdrawn
- 2007-12-19 WO PCT/US2007/088225 patent/WO2008077130A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CA2673193A1 (fr) | 2008-06-26 |
MX2009006656A (es) | 2009-08-07 |
EP2101736A2 (fr) | 2009-09-23 |
EP2101736A4 (fr) | 2012-09-19 |
WO2008077130A3 (fr) | 2008-08-21 |
WO2008077130A2 (fr) | 2008-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080027011A1 (en) | Homogeneous paste and gel formulations | |
CA2634394C (fr) | Formulations de pates homogenes | |
ES2743673T3 (es) | Composiciones parasiticidas orales veterinarias que comprenden agentes activos de acción sistémica, procedimientos y usos de las mismas | |
JP2005533806A (ja) | 駆虫性動物用均質経口ペースト | |
US20170354593A1 (en) | Palatable chewable veterinary composition | |
RU2002124584A (ru) | Фармацевтические и ветеринарные пастообразные композиции | |
TWI433691B (zh) | 苯并咪唑之非水性組合物 | |
CA2673193C (fr) | Preparations homogenes de pate et de gel | |
KR20200085810A (ko) | 주사가능한 이속사졸린 제약 조성물 및 그의 기생충 침입에 대한 용도 | |
ES2366109T3 (es) | Formulaciones antihelmínticas. | |
CN110721152B (zh) | 一种治疗动物皮肤寄生虫、真菌感染的缓释组合物 | |
BR112020010291A2 (pt) | composição contendo moxidectina para tratamento de infestações de parasitas | |
AU2007100254B4 (en) | Improved parasiticide paste | |
AU2003238245B2 (en) | Anthelmintic oral homogeneous veterinary pastes | |
BR102013017846A2 (pt) | Nanoformulações e submicroformulações com ativos ultraconcentrados com dendrímeros a base de antiespasmódicos e/ou aines (anti-inflamatórios não hormonais) e/ou anti-histamínicos ou aies (anti-inflamatórios hormonais) e/ou ciclosporinas com a finalidade de redimir sintomas de inflamações, cólicas, pruridos e dor em bovinos, suínos, caprinos, ovinos, caninos e felinos ou benzoil uréia e/ou acil uréia e/ou avermectinas isoladamente ou combinada com vermífugo e/ou inseticidas para o controle e prevenção de endo e ectoparasitas em bovinos, suínos, caprinos, ovinos, caninos, felinos e aves |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |